Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Upstream Bio (UPB) Restructuring Costs (2024 - 2025)

Upstream Bio has reported Restructuring Costs over the past 2 years, most recently at $1.3 million for Q4 2025.

  • Quarterly results put Restructuring Costs at $1.3 million for Q4 2025, up 56.58% from a year ago — trailing twelve months through Dec 2025 was $4.5 million (up 127.77% YoY), and the annual figure for FY2025 was $4.5 million, up 127.77%.
  • Restructuring Costs for Q4 2025 was $1.3 million at Upstream Bio, up from $891000.0 in the prior quarter.
  • Over the last five years, Restructuring Costs for UPB hit a ceiling of $1.3 million in Q4 2025 and a floor of $334000.0 in Q2 2024.